Oligometastatic
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer (NCT06942416) | Shandong Cancer Hospital and Institute | 2025-02-28 |
| Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial (NCT06593431) | M.D. Anderson Cancer Center | 2024-10-23 |
Track Oligometastatic automatically
Every clearance here is in the API, with alerts when new ones post.